Shares: Taking Stock
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Proteus International, the healthcare group, rose 23p to 83p as the Irish offered what could be a break- through for its BSE diagnostic system.
A 168-strong supermarket chain is selling BSE tested and labelled beef. The tests are carried out by a Proteus licensee at its laboratory outside Dublin. Beef carcasses are examined for pounds 20 a time with royalties paid to Proteus.
Aromascan fell 2.5p to 12p. It confirmed a nominee company had sold a 4.9 per cent stake. The deal took place on the day Aromascan said it knew of no reason for any share weakness.
Versailles, a trade finance group, should lift profits by more than pounds 2m to pounds 7.2m this year and pounds 2m to pounds 9m next, believes stockbroker Teather & Greenwood. The shares are 47.5p.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments